HTR1A and myeloid sarcoma: The results showed that the expression of 5-HT1A receptor was significantly decreased in the cerebral hippocampus of adult MS male rats in the model group compared with the control group, and SNS treatment markedly reversed the downregulation compared with the MS rats in the model group (Figure 9F).